🇺🇸 FDA
Patent

US 8246984

Formulation of insoluble small molecule therapeutics in lipid-based carriers

granted A61KA61K31/538A61K31/70

Quick answer

US patent 8246984 (Formulation of insoluble small molecule therapeutics in lipid-based carriers) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/538, A61K31/70, A61K9/127, A61P